Coronary Artery Disease Stable | Gender | Postmenopausal state
Item
stable cad patients (men & postmenopausal women)
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
Age
Item
aged 20-80 years
boolean
C0001779 (UMLS CUI [1])
Body Weight | Body mass index
Item
weighing less than 115 kg (bmi range 18.5-35 kg/m2)
boolean
C0005910 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Coronary Artery Disease | Lesion Coronary angiography | Myocardial Infarction | Stress Test Positive
Item
with coronary artery disease defined by the presence of lesions on coronary angiography, history of myocardial infarction, or positive stress test.
boolean
C1956346 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C0085532 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C3494508 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
Stenting Status post Stable
Item
subjects are eligible to participate after a stent procedure only after they have been stable for one month after the stent procedure.
boolean
C2348535 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Ethnic group All
Item
all ethnic groups.
boolean
C0015031 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
English Language
Item
languages: english
boolean
C0376245 (UMLS CUI [1])
Heart failure
Item
subjects with heart failure are not eligible for participation in this study.
boolean
C0018801 (UMLS CUI [1])
Nut Hypersensitivity
Item
history or known allergy to nuts of any kind
boolean
C0577620 (UMLS CUI [1])
Urine pregnancy test Beta HCG positive | Breast Feeding | Pregnancy, Planned
Item
women with a positive urine beta hcg pregnancy test and lactating women or women who are planning to become pregnant.
boolean
C0430056 (UMLS CUI [1,1])
C0813152 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Consumption Nuts oz/week
Item
regular consumption of ≥ 5 oz nuts/week for 6 weeks prior to study admission
boolean
C0009830 (UMLS CUI [1,1])
C0028723 (UMLS CUI [1,2])
C0556977 (UMLS CUI [1,3])
Illness Major | End stage cancer | Kidney Failure | Liver Failure | Gastrointestinal Diseases Impairing Absorption | Condition Study Subject Participation Status Inappropriate
Item
clinical history of other major illness including end-stage cancer, renal failure, hepatic failure, gastrointestinal disorders that may impair absorption, or other conditions that in the opinion of the principal investigator make a clinical study inappropriate.
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0741884 (UMLS CUI [2])
C0035078 (UMLS CUI [3])
C0085605 (UMLS CUI [4])
C0017178 (UMLS CUI [5,1])
C0221099 (UMLS CUI [5,2])
C0237442 (UMLS CUI [5,3])
C0348080 (UMLS CUI [6,1])
C2348568 (UMLS CUI [6,2])
C1548788 (UMLS CUI [6,3])
Steroids Oral Regular
Item
regular use of oral steroids
boolean
C0038317 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205272 (UMLS CUI [1,3])
Tobacco use | Nicotine Replacement Products
Item
cigarette smoking and/or nicotine replacement use
boolean
C0543414 (UMLS CUI [1])
C3179143 (UMLS CUI [2])
Alcohol consumption Drinks U/day
Item
regular daily intake of ≥ 2 alcoholic drinks
boolean
C0001948 (UMLS CUI [1,1])
C0001967 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Illicit medication use
Item
illicit drug use
boolean
C0281875 (UMLS CUI [1])
Psychological disease Interferes with Comprehension Study Protocol | Mental condition Interferes with Comprehension Study Protocol
Item
history of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study.
boolean
C1658764 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Dietary Supplements Containing Phenolics | Plant Preparations | Berry preparation | Cranberry Capsule
Item
no dietary supplements containing phenolic compounds, i.e., herbal preparations, or berry containing preparations (such as cranberry capsules) for one month prior to study admission.
boolean
C0242295 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0359916 (UMLS CUI [1,3])
C0949854 (UMLS CUI [2])
C3495134 (UMLS CUI [3])
C1249096 (UMLS CUI [4])
Investigational New Drugs
Item
treatment with an investigational new drug within the last 30 days.
boolean
C0013230 (UMLS CUI [1])
Vitamin E | Ascorbic Acid | Beta Carotene | Thioctic Acid | Dietary Supplements | Herbal Supplements
Item
treatment with vitamin e, vitamin c, beta carotene, lipoic acid, or other food or herbal supplements within 1 month of enrollment (subjects taking multivitamins or other forms of vitamin e and c in doses that do not exceed two times the rda will not be excluded).
boolean
C0042874 (UMLS CUI [1])
C0003968 (UMLS CUI [2])
C0053396 (UMLS CUI [3])
C0023791 (UMLS CUI [4])
C0242295 (UMLS CUI [5])
C1504473 (UMLS CUI [6])
Pharmaceutical Preparations Absent Ultrasonography
Item
the following medications will be withheld in the morning of each ultrasound study visit as follows:
boolean
C0013227 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0041618 (UMLS CUI [1,3])
Vasoactive agent | Nitrates | Calcium Channel Blockers | Adrenergic beta-1 Receptor Antagonists | Angiotensin-Converting Enzyme Inhibitors | Vasodilator Agents | Pharmaceutical Preparations Intake Post Ultrasonography
Item
all vasoactive medications (nitrates, calcium channel blockers, beta blockers, angiotensin converting enzyme inhibitors, and other vasodilators). subjects will take their medications immediately after the ultrasound measurements are taken.
boolean
C0597639 (UMLS CUI [1])
C0028125 (UMLS CUI [2])
C0006684 (UMLS CUI [3])
C0304516 (UMLS CUI [4])
C0003015 (UMLS CUI [5])
C0042402 (UMLS CUI [6])
C0013227 (UMLS CUI [7,1])
C1512806 (UMLS CUI [7,2])
C0687676 (UMLS CUI [7,3])
C0041618 (UMLS CUI [7,4])